Trade Setup Buy Target $2.63 Sell Target $3.27 AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the United States. The company’s products include Alferon N Injection, an injectable formulation of natural alpha interferon to treat a category of genital […]
Read MoreTrade Setup Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .50 and $3, with at least 50k shares of average shares trading per day. The stocks are starting new uptrends and have buy signals. These are high reward to risk stocks with the potential for very sharp moves. A stop […]
Read MoreTrade Setup Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .50 and $3, with at least 50k shares of average shares trading per day. The stocks are starting new uptrends and have buy signals. These are high reward to risk stocks with the potential for very sharp moves. A stop […]
Read MoreTrade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day. The stocks are pausing a trend either up or down, with a new bar over the prior day open or close. These are high reward to risk stocks with the […]
Read MoreBuy Price: $28.50 or better Sell Price: TradersPro Sell Signal MarineMax, Inc. operates as a recreational boat and yacht retailer in the United States. The company sells new and used recreational boats, including pleasure boats, such as sport boats, sport cruisers, sport yachts, and other yachts; fishing boats; motor and convertible yachts; pontoon boats; fishing […]
Read MorePlus, Delta reported a $5.4 billion loss, AMC said it could run out of money by early 2021 as movie theaters continue struggle amid the ongoing coronavirus, and Disney announced a reorganization to focus its media and entertainment business on streaming.
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read More